Personalized medicine could mean big business for D.C.-area companies, The Washington Post, May 31, 2015
The American health-care industry’s pivot to personalized medicine has attracted the interest of an unlikely group of companies — government contractors.
As health-care providers explore this new model of treatment, which involves the study of the human genome to provide personalized care, they face a problem with which many in government are familiar: analyzing an overwhelming amount of data. Read more.